Types of FDA Regulatory Submissions: Your Comprehensive Guide

Grace Aug 20, 2026

The U.S. Food and Drug Administration (FDA) regulates a broad range of products, from drugs and medical devices to food and cosmetics. As part of its mandate, the FDA accepts various types of regulatory submissions to ensure the safety, efficacy, and quality of these products. This article delves into the different types of FDA regulatory submissions, their purposes, and when they are typically used.

US FDA 510(k) Submission Process – Your Pathway to U.S. Market Clearance
US FDA 510(k) Submission Process – Your Pathway to U.S. Market Clearance

Understanding these submissions is crucial for companies navigating the complex process of bringing products to market in the U.S. They also play a significant role in maintaining FDA compliance throughout a product's lifecycle. Let's explore the key types of FDA regulatory submissions.

FDA restructuring food program
FDA restructuring food program

Pre-Market Submissions

Pre-market submissions are used to introduce new products or significant modifications to existing ones. They are crucial for ensuring that new products meet the FDA's standards before they enter the market.

10 Things You Need to Know About the FDA
10 Things You Need to Know About the FDA

The most common pre-market submissions are:

New Drug Application (NDA)

An Overview of FDA Regulations for Medical Devices
An Overview of FDA Regulations for Medical Devices

An NDA is submitted for approval of a new drug, including new active ingredients, new combinations of active ingredients, or new indications for an existing drug. It includes data from preclinical (animal) and clinical (human) studies that demonstrate the drug's safety and efficacy.

Examples of NDAs include applications for novel drugs, new formulations of existing drugs (such as extended-release versions), or drugs approved in other countries but not yet in the U.S.

Biologics License Application (BLA)

a diagram showing the four areas of regulatory afairs, including advertising and promotion
a diagram showing the four areas of regulatory afairs, including advertising and promotion

A BLA is used to approve a biologic product, such as a vaccine, blood derivative, allergenic extract, cell or tissue-based product, gene therapy, or monoclonal antibody. BLAs use a similar format to NDAs but must also include data on the product's design, manufacturing, control, and stability.

Examples of BLAs include applications for new biologics, new indications for existing biologics, or new manufacturing processes for approved biologics.

Post-Market Submissions

The case for creating excess capacity at the US Food and Drug Administration
The case for creating excess capacity at the US Food and Drug Administration

Post-market submissions are used to keep the FDA informed about changes to products that are already on the market. They help ensure the ongoing safety, efficacy, and quality of these products.

Key post-market submissions include:

medical devie regulatory affairs course
medical devie regulatory affairs course
How Regulatory Data Submissions Shape Global Healthcare
How Regulatory Data Submissions Shape Global Healthcare
Ensure Safety and Quality with FDA Regulations! 🏥🔬
Ensure Safety and Quality with FDA Regulations! 🏥🔬
US FDA consultant
US FDA consultant
FDA
FDA
FDA Ai Compliance Audits
FDA Ai Compliance Audits
Common Reasons Regulatory Submissions Get Delayed
Common Reasons Regulatory Submissions Get Delayed
Advancing Regulatory Science
Advancing Regulatory Science
How the EU AI Act Will Impact Pharmaceutical Regulatory Submissions
How the EU AI Act Will Impact Pharmaceutical Regulatory Submissions

Supplement/Priority Review

A supplement is used to request approval for a significant change to an already-approved product. It can involve a new indication, a change to the product formulation or manufacturing process, or a new dosing regimen. Priority review is a process for expediting the review of supplements based on specific criteria.

Examples of supplements include applications for a new indication, a new formulation, or a new manufacturing site.

Annual Report

Manufacturers of certain drugs, biologics, and medical devices are required to submit annual reports to the FDA. These reports provide the FDA with updates on the product's safety, efficacy, and quality, including any changes that occurred during the year.

Examples of annual reports include those for Prescription Drug User Fee Act (PDUFA) products, Medical Device User Fee Act (MDUFA) products, and certain biologics.

The FDA's regulatory submission process is complex but essential for maintaining product quality and safety. By understanding the various submission types, companies can effectively navigate the FDA approval and compliance landscape.